HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$106.94
Tradestie Score
52
Market Cap
$8.77B
P/E Ratio
32.4
Revenue Growth
0.5%
Analyst Upside
-6.9%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$140.71
|
$13.59B | 21.3 | 54 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.31
|
$12.36B | 17.9 | 69 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.50
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$188.94
|
$10.74B | - | 36 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.44
|
$10.53B | 162.2 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.00
|
$10.49B | - | 68 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.91
|
$10.22B | - | 73 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$499.71
|
$10.01B | - | 53 | Compare |
More HALO Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry